Natural compounds as potential treatments of NF2-deficient schwannoma and meningioma: Cucurbitacin D and goyazensolide

Otology and Neurotology

Volumn 34, Issue 8, 2013, Pages 1519-1527

  Spear, Samuel A ^a,b   Burns, Sarah S ^a,b   Oblinger, Janet L ^a,b   Ren, Yulin ^d   Pan, Li ^d   Kinghorn, A Douglas ^d   Welling, D Bradley ^b   Chang, Long Sheng ^a,b,c  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b Departments of Otolaryngology   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

Cucurbitacin D; Goyazensolide; Meningioma; Natural compounds; Neurofibromatosis type 2; Vestibular schwannoma

Indexed keywords

ANTINEOPLASTIC AGENT; BRIDGED COMPOUND; CUCURBITACIN D; FURAN DERIVATIVE; FURANOHELIANGOLIDE; MERLIN; TRITERPENE;

ANIMAL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN HEPG2; DRUG EFFECT; HUMAN; MENINGIOMA; METABOLISM; MOUSE; NEURILEMOMA; PATHOLOGY; DRUG EFFECTS; HEPG2 CELL LINE; MENINGEAL NEOPLASMS; NEURILEMMOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BRIDGED COMPOUNDS; CELL CYCLE; CELL PROLIFERATION; FURANS; HEP G2 CELLS; HUMANS; MENINGEAL NEOPLASMS; MENINGIOMA; MICE; NEURILEMMOMA; NEUROFIBROMIN 2; TRITERPENES;

EID: 84885018890     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e3182956169     Document Type: Article

References (26)

1. James M. Cell culture of neurofibromatosis type 2-associated tumors. In: Cunha KSG, Geller M, eds. Advances in Neurofibromatosis Research. New York, NY: Nova Science Publishers, Inc, 2012;181-204.
2. Yates C, Welling DB, Chang LS. Research advances in therapeutics for neurofibromatosis type 2-associated vestibular schannomas. In: Cunha KSG, Geller M, eds. Advances in Neurofibromatosis Research. New York, NY: Nova Science Publishers, Inc, 2012;221-36.
3. Giovannini M, Peyre M, Bonne NX, et al. Mouse models in neurofibromatosis type 2. In: Cunha KSG, Geller M, eds. Advances in Neurofibromatosis Research. New York, NY: Nova Science Publishers, Inc, 2012;205-20.
4. Nobili S, Lippi D, Witort E, et al. Natural compounds for cancer treatment and prevention. Pharmacol Res 2009;59:365-78.
5. Balunas MJ, Jones WP, Chin Y-W, et al. Relationships between inhibitory activity against a cancer cell line panel, profiles of plants collected, and compound classes isolated in an anticancer drug discovery project. Chem. Biodivers 2006;3:897-915.
6. Boykin C, Zhang G, Chen YH, et al. Cucurbitacin IIa: a novel class of anticancer drug inducing non-reversible actin aggregation and inhibiting surviving independent of JAK2/STAT3 phosphorylation. Br J Cancer 2011;104:781-9.
7. Lee DH, Iwanski GB, Thoennissen NH. Cucurbitacin: ancient compound shedding new light on cancer treatment. Scientific World J 2010;10:413-8.
8. Pan L, Yong Y, Deng Y, et al. Isolation, structure elucidation, and biological evaluation of 16,23-epoxycucurbitacin constituents from Eleaocarpus chinensis. J Nat Prod 2012;75:444-52.
9. Orofino Kreuger MR, Grootjans S, Biavatti MW, et al. Sesquiterpene lactones as drugs with multiple targets in cancer treatment: focus on parthenolide. Anticancer Drugs 2012;23:883-96.
10. Ren Y, Acuna U, Jimenez F, et al. Cytotoxic and NF-JB inhibitory sesquiterpene lactones from Piptocoma rufescens. Tetrahedron 2012; 68:2671-8.
11. Giovannini M, Robanus-Maandag E, van der Valk M, et al. Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev 2000;14: 1617-30.
12. Püttmann S, Senner V, Braune S, et al. Establishment of a benign meningioma cell line by hTERT-mediated immortalization. Lab Invest 2005;85:1163-71.
13. Fields RD, Lancaster MV. Dual attribute continuous monitoring of cell proliferation/cytotoxicity. Am Biotechnol Lab 1993;11:48-50.
14. Lee TX, Packer MD, Huang J, et al. Growth inhibitory and antitumor activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cells. Eur J Cancer 2009; 45:1709-20.
15. Ito A, Chai H-B, Lee D, et al. Ellagic acid derivatives and cytotoxic cucurbitacins from Elaeocarpus mastersii. Phytochemistry 2002;61: 171-4.
16. Wagner S, Hofmann A, Siedle B, et al. Development of a structural model for NF-kappaB inhibition of sesquiterpene lactones using self-organizing neural networks. J Med Chem 2006;49:2241-52.
17. Dirks MS, Butman JA, Kim HJ, et al. Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors. J Neurosurg 2012;117:109-17.
18. Demestre M, Messerli SM, Celli N, et al. CAPE (caffeic acid phenethyl ester)-based propolis extract (Bio 30) suppresses the growth of human neurofibromatosis (NF) tumor xenografts in mice. Phytother Res 2009;23:226-30.
19. Messerli SM, Ahn MR, Kunimasa K, et al. Artepillin C (ARC) in Brazilian green propolis selectively blocks oncogenic PAK1 signaling and suppresses the growth of NF tumors in mice. Phytother Res 2009;23:423-7.
20. Angelo LS, Wu JY, Meng F, et al. Combining curcumin (diferuloylmethane) and heat shock protein inhibition for neurofibromatosis 2 treatment: analysis of response and resistance pathways. Mol Cancer Ther 2011;10:2094-103.
21. Lee JD, Lee JY, Byoung JB, et al. The inhibitory effect of honokiol, a natural plant product, on vestibular schwannoma cells. Laryngoscope 2012;122:162-6.
22. Zhu JS, Ouyang DY, Shi ZJ, et al. Cucurbitacin B induces cell cycle arrest, apoptosis and autophagy associated with G actin reduction and persistent activation of cofilin in Jurkat cells. Pharmacology 2012;89:348-56.
23. Banerjee S, Byrd JN, Gianino SM, et al. The neurofibromatosis type 1 tumor suppressor controls cell growth by regulating signal transducer and activator of transcription-3 activity in vitro and in vivo. Cancer Res 2010;70:1356-66.
24. Barbercheck ME, Wang J. Effect of cucurbitacin D on in vitro growth of Xenorhabdus and Photorhabdus spp., symbiotic bacteria of entomopathogenic nematodes. J Invertebr Pathol 1996;68:141-5.
25. Takahashi N, Yoshida Y, Sugiura T, et al. Cucurbitacin D isolated from Trichosanthes kirilowii induces apoptosis in human hepatocellular carcinoma cells in vitro. Int.Immunopharmacol 2009;9: 508-13.
26. Blaskovich MA, Sun J, Cantor A, et al. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res 2003;63:1270-9.